TrialLangenbeck's archives of surgery2017

Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.

Gencay Hatiboglu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.